首页> 外文期刊>Australasian Medical Journal >The lowest dose of corticosteroids, which stops the episodes of PFAPA syndrome
【24h】

The lowest dose of corticosteroids, which stops the episodes of PFAPA syndrome

机译:皮质类固醇的最低剂量,可停止PFAPA综合征的发作

获取原文
       

摘要

Background The episodes of PFAPA syndrome with their exhausting periodic fever, annoying oral aphthae and sore throat, warrant treatment. Corticosteroids are the most efficacious. Aims Providing evidence that a weight-independent, minimal dose of betamethasone, the least ever used, can resolve symptoms of PFAPA syndrome, within few hours. Methods In a retrospective case-series analysis study, approved by the relevant ethical committees of Clalit Health Organization, we collected analysed and interpreted data from medical files of children who suffered from PFAPA syndrome, during 1998 until 2015, concerning the lowest effective betamethasone dose, they received and which had abated fever within few hours. Results We had diagnosed 132 children of our 2300 children community, as suffering from PFAPA syndrome (rate 6 per cent). Ninety eight per cent of the patients satisfactorily responded, within two-to-twelve hours, to treatment with a minimal one-time weight-independent dose of betamethasone in every flare. The rest of patients (2 per cent) needed an equal second dose to end their first flare during the following twelve hours. Three patients who were four to five-months-old at time of diagnosis, had received 0.1mg dose. Conclusion A dose of 0.5mg of betamethasone for children under 5 years of age and a dose of 1.0mg was prescribed for children >5, were effective for prompt resolution of PFAPA flares. We believe that as long as there is an effective lowest dose for treating PFAPA episodes, a great reduction of corticosteroid consumption will be exercisable globally.
机译:背景PFAPA综合征的发作,包括持续的发烧,令人讨厌的口腔口疮和喉咙痛,因此值得治疗。皮质类固醇最有效。目的提供证据,证明与体重无关的最小剂量倍他米松(最少使用)可以在几小时内解决PFAPA综合征的症状。方法在一项由Clalit卫生组织有关伦理委员会批准的回顾性病例系列分析研究中,我们收集了1998年至2015年期间患有PFAPA综合征的儿童的医疗档案中有关最低有效倍他米松剂量的分析和解释数据,他们接受了治疗,并在几个小时内发烧减轻。结果我们已经诊断出2300个儿童社区中的132名儿童患有PFAPA综合征(比率为6%)。 98%的患者在两到十二小时内满意地对每次发作使用最小一次的体重无关剂量倍他米松进行治疗。其余的患者(2%)需要等量的第二剂才能在接下来的十二小时内结束其首次发作。在诊断时四至五个月大的三名患者接受了0.1mg剂量。结论5岁以下儿童服用0.5mg倍他米松,大于5岁儿童服用1.0mg倍他米松,对于迅速消退PFAPA发作有效。我们相信,只要有治疗PFAPA发作的有效最低剂量,全球范围内就可以大幅度减少皮质类固醇的消耗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号